Acer Therapeutics Inc. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 15, 2016

Attached files

file filename
EX-32.1 - CERTIFICATION - Acer Therapeutics Inc.ex_321.htm
EX-4.13 - AMENDED AND RESTATED SERIES N WARRANTS - Acer Therapeutics Inc.ex413.htm
EX-31.2 - CERTIFICATION - Acer Therapeutics Inc.ex_312.htm
EX-31.1 - CERTIFICATION - Acer Therapeutics Inc.ex_311.htm
EX-32.2 - CERTIFICATION - Acer Therapeutics Inc.ex_322.htm
EX-10.21 - AMENDMENT TO STOCK PURCHASE AGREEMENT - Acer Therapeutics Inc.ex_1021.htm
EX-10.22 - OFFER LETTER - Acer Therapeutics Inc.ex_1022.htm
10-K - ANNUAL REPORT - Acer Therapeutics Inc.opxa_10k.htm

EXHIBIT 23.1
 

 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statements on Form S-1 (File No. 333-201731), Form S-3 (File No. 333-191655, 333-185003, 333-185001 and 333-208314) and Form S-8 (File No. 333-192215, 333-176934 and 333-139196) of our report dated March 15, 2016 with respect to the audited consolidated financial statements of Opexa Therapeutics, Inc. as of December 31, 2015 and 3014 and for the years then ended.

We also consent to the references to us under the heading “Experts” in such Registration Statements.

/s/ MaloneBailey, LLP
www.malonebailey.com
Houston, Texas
March 15, 2016

Acer Therapeutics Inc. Reports